Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 18/6/2018
SIETES contiene 92381 citas

 
 
 1 a 20 de 1736 siguiente >>
Presentar resultados
Seleccionar todas
2.Enlace a cita original Cita con resumen
Liljenquist D, Bai G, Anderson GF. Addressing generic-drug market failures — The case for establishing a nonprofit manufacturer. N Engl J Med 2018;378:17 de mayo. [Ref.ID 102608]
3. Cita con resumen
Feuerstein A. After watching Trump’s drug speech, investors poured big money into biotech funds. STAT Daily Recap 2018:4. [Ref.ID 102605]
4.Enlace a cita original Cita con resumen
Garattini S, Bertele V. Benefits, benefits, once more benefits... with no risk? Stop overlooking the harms of medicines. Eur J Clin Pharmacol 2018;74:marzo. [Ref.ID 102550]
5. Cita con resumen
Darrow JJ, Avorn J, Kesselheim AS. The FDA breakthrough-drug designation - Four years of experience. N Engl J Med 2018;378:16 de abril. [Ref.ID 102515]
6. Cita con resumen
Silverman E. STAT Plus: Spending growth on prescription drugs will double this year. STAT Daily Recap 2018:3. [Ref.ID 102457]
8. Cita con resumen
Anónimo. GSK cuts back operations in Africa. DIA Daily 2018:1. [Ref.ID 102445]
9. Cita con resumen
Anónimo. Dutch health minister considers compulsory license over drug prices. DIA Daily 2017:1. [Ref.ID 102148]
10. Cita con resumen
Anónimo. More doctors disclose payments from drug companies . BMJ 2017;358:30 de junio. [Ref.ID 101667]
11. Cita con resumen
Anónimo. FDA announces list of off-patent drugs with no competition. DIA Daily 2017:1. [Ref.ID 101658]
12. Cita con resumen
Armstrong D. Kentucky Senate president urges release of secret OxyContin records. STAT 2017:28 de junio. [Ref.ID 101657]
13. Cita con resumen
Larkin I, Ang D, Steinhart J, Chao M, Patterson M, Sah S, Wu T, Schoen-baum M, Hutchins D, Brennan T, Loewen-stein G. Association between academic medical center pharmaceutical detailing policies and physician prescribing. JAMA 2017;317:1785-95. [Ref.ID 101559]
14. Cita con resumen
Anónimo. FDA pushes back on Trump’s claims of slow drug reviews. DIA Daily 2017:8. [Ref.ID 101452]
16. Cita con resumen
19.Enlace a cita original Cita con resumen
Anónimo. Access to medicines—the status quo is no longer an option. Lancet 2016;388:1250. [Ref.ID 100699]
20. Cita con resumen
Anónimo. UN panel questions free market approach to R&D for medicines. DIA Daily 2016:1. [Ref.ID 100664]
Seleccionar todas
 
 1 a 20 de 1736 siguiente >>